Genital Diseases, Male  >>  mipsagargin (G-202)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mipsagargin (G-202) / Rebus
NCT01734681 / 2011-002149-36: Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

Withdrawn
2
0
US
G-202
GenSpera, Inc.
Prostate Cancer.
01/15
01/15
NCT02381236: G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer

Completed
2
1
US
G-202, Mipsagargin
GenSpera, Inc.
Prostatic Neoplasms
12/16
02/17

Download Options